|
FOR IMMEDIATE RELEASE |
|||||||||||
|
Albuquerque, NM, May 1, 2001 - Novint Technologies, Inc., a unit of Manhattan Scientifics, Inc. (MHTX), announced today that it has reached agreement for joint beta research projects with two of the world's ten largest oil companies aimed at integrating Novint's e-Touch technology into their petroleum exploration modeling applications.
The revolutionary e-Touch software enables anyone to use the sense of touch to interact effectively and naturally with complex three-dimensional data. Sometimes referred to as "force feedback" or "haptics," the technology was developed at the Sandia National Laboratory and licensed exclusively to Novint Technologies, a partially owned unit of Manhattan Scientifics.
"We believe Novint is positioned to become a leader in applying touch technology and virtual reality to the challenges of identifying petroleum resources," said Manhattan Scientifics CEO Marvin Maslow. "Novint Technologies' e-Touch software is a powerful and effective interface when working with complex oil exploration data models. Novint's petroleum partners are enthusiastic about the potential benefits of touch interaction in enhancing and accelerating the process of identifying oil prospects."
Tom Anderson, Novint CEO and the inventor of the e-Touch software, said, "At Novint, we have created a 3D touch user interface software that allows people to use their hands in the digital world in the same way that they do in the real world - naturally and intuitively. When integrated into an oil exploration software application, the e-Touch software significantly reduces the time it takes to interpret 3D data, while enabling a geophysicist to feel as well as see sub-surface structures. It is very exciting to develop contracts with two of the world's largest petroleum companies at the same time."
Novint Technologies was founded in Albuquerque, NM in 1999 by Tom Anderson, a former scientist at Sandia Labs. Novint specializes in developing software that allows users to work in the virtual world the way they would in the real world, naturally and in 3D. Novint is a partner company of Manhattan Scientifics, Inc. a public company that nurtures emerging technologies to commercial products that have global implications. Additional information about Novint and e-Touch may be found on the Novint website.
Manhattan Scientifics, Inc. is an investment and development company focused on various technologies including fuel cells and alternative energy, holographic data storage, water and gas filtration and computer and Internet enhancements. Manhattan Scientifics is a major investor in Novint. The company's development laboratories are located in Los Alamos and Albuquerque, NM and Passau, Germany. Its executive office is in New York City at 641 Fifth Avenue, Suite 36F, New York, 10022. Copies of Manhattan Scientifics' press releases, current quotes, stock charts and other information for investors may be found on the websites www.mhtx.com and www.hawkassociates.com.
This press release may contain forward-looking statements (including without limitation regarding future business), which are based largely on company expectations and are subject to risks and uncertainties which may be beyond company control. Actual results could differ materially due to numerous factors, including without limitation successful completion and funding of technology research and development, successful technology commercialization, successful protection of intellectual property, market conditions, and the effects of industry competition. NovArs GmbH, ERDI, and Novint Technologies, Inc. are independent contractors to the company from whom company acquired certain intellectual property rights. In light of these risks and uncertainties there can be no assurances that the forward-looking statements in this press release will in fact transpire or prove to be accurate.
Executive Contact:
Tom Anderson
Investor Relations Contact:
Media Relations Contact:
This press release may contain forward-looking statements (including without limitation regarding future business) which are based largely on company expectations and are subject to risks and uncertainties which may be beyond company control. Actual results could differ materially due to numerous factors, including without limitation successful completion and funding of technology research and development, successful technology commercialization, successful protection of intellectual property, market conditions, and the effects of industry competition. NovArs GmbH, ERDI, and Novint Technologies, Inc. are independent contractors to the company from whom company acquired certain intellectual property rights. In light of these risks and uncertainties there can be no assurances that the forward-looking statements in this press release will in fact transpire or prove to be accurate.
######END###### ********** Manhattan Scientifics, Inc. Olympic Tower, 641 Fifth Avenue, Suite 36F, New York, NY 10022 Tel: (212) 752-0505 Fax: (212) 752-0077 - http://www.mhtx.com |
|||||||||||
|
|
|||||||||||
| Media Contact: Alex Stanton/Peter Engel Stanton-Crenshaw Tel: (212) 780-1900 Email: pengel@stanton-crenshaw.com http://www.stanton-crenshaw.com |
Institutional Investor Relations: Frank Hawkins/Julie Marshall Hawk Associates Tel: (305) 852-2383 Email: Fhawk@hawkassociates.com http://www.hawkassociates.com |
||||||||||
![]() |
|||||||||||